fbpx

News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.

Phase 1b/2 Study of Margetuximab in Combination with Pembrolizumab Presented at 2018 ASCO Gastrointestinal Cancers Symposium

At ASCO this weekend, new data was shared from a clinical trial of margetuximab and pembrolizumab for patients with advanced gastric cancer, where researchers are “… encouraged by the tolerability and anti-tumor activity of this novel, chemotherapy-free regimen…”

Read Source
Please join with us to fuel the next wave of progress.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.
Please join with us to fuel the next wave of progress. Support our 2024 Fundraising Campaign.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.

Together, we will defeat stomach cancer.

Together, we will defeat stomach cancer.

MORE INFODONATE
X